3-Fluoro-2-(pyrimidin-2-yl)benzoic acid, 97%, 100mg

4-(2-Methoxyphenyl)piperidine, 97.0%, 5g

1,4-Diaminobutane>98.0%(GC)(T)400g

6-Methyl-2-trifluoromethyl-thiazolo[3,2-b][1,2,4]triazole-5-carboxylic acid, 95.0%, 1g

5-BROMO-4-CHLORO-1H,2H,3H-PYRROLO[2,3-B]PYRIDIN-2-ONE, 95.0%, 100mg

Ammonium heptamolybdate tetrahydrate, min. 99%, pa, 1 kg, plastic packaging.

GC capillary column ROTI®Cap-5, 60 m, 0.32 mm, 3.00 µm, 1 Piece(s)

1-BOC-4-HYDROXY-PIPERIDINE-4-CARBOXYLIC ACID METHYL ESTER, 95.0%, 5g

2-AMINOETHYL ACETATE HCL, 95.0%, 250mg

Sodium 3-fluorobenzoate, 95.0%, 10g

Sample vials ROTILABO® with beaded rim, 2 ml, 200 Piece(s)

2-(3-Chloro-4-fluoro-5-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 5g

6-Thia-2-azaspiro[3.4]octane 6,6-dioxide hydrochloride, 98%, 250mg